Mesoblast Limited

Mesoblast Limitedverified

MESO

Price:

$17.19

Market Cap:

$2.26B

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company's products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection; Rexle...[Read more]

Industry

Biotechnology

IPO Date

2010-01-20

Stock Exchange

NASDAQ

Ticker

MESO

The Enterprise Value as of December 2025 (TTM) for Mesoblast Limited (MESO) is 2.23B

According to Mesoblast Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.23B. This represents a change of 173.72% compared to the average of 814.00M of the last 4 quarters.

Mesoblast Limited (MESO) Historical Enterprise Value (quarterly & annually)

How has MESO Enterprise Value performed in the past?

The mean historical Enterprise Value of Mesoblast Limited over the last ten years is 700.17M. The current 2.23B Enterprise Value has changed 31.72% with respect to the historical average. Over the past ten years (40 quarters), MESO's Enterprise Value was at its highest in in the December 2024 quarter at 2.28B. The Enterprise Value was at its lowest in in the June 2025 quarter at -33001000.00.

Quarterly (TTM)
Annual

Average

700.17M

Median

646.14M

Minimum

305.83M

Maximum

1.21B

Mesoblast Limited (MESO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mesoblast Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.54%

Maximum Annual Enterprise Value = 1.21B

Minimum Annual Increase = -73.32%

Minimum Annual Enterprise Value = 305.83M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20251.21B70.08%
2024713.46M23.70%
2023576.75M88.59%
2022305.83M-62.77%
2021821.52M-26.20%
20201.11B107.54%
2019536.33M-7.34%
2018578.82M-23.81%
2017759.69M98.49%
2016382.73M-73.32%

Mesoblast Limited (MESO) Average Enterprise Value

How has MESO Enterprise Value performed in the past?

The current Enterprise Value of Mesoblast Limited (MESO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

834.55M

5-year avg

726.20M

10-year avg

700.17M

Mesoblast Limited (MESO) Enterprise Value vs. Peers

How is MESO’s Enterprise Value compared to its peers?

Mesoblast Limited’s Enterprise Value is greater than Ocular Therapeutix, Inc. (1.89B), less than Edgewise Therapeutics, Inc. (2.47B), greater than Galapagos N.V. (1.73B), greater than Structure Therapeutics Inc. (1.75B), greater than uniQure N.V. (699.95M), less than Viridian Therapeutics, Inc. (2.54B), less than Liquidia Corporation (2.94B), less than Nuvation Bio Inc. (2.75B), less than ImmunityBio, Inc. (2.24B), less than Cogent Biosciences, Inc. (5.53B),

Build a custom stock screener for Mesoblast Limited (MESO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mesoblast Limited (MESO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Mesoblast Limited's Enterprise Value?

What is the highest Enterprise Value for Mesoblast Limited (MESO)?

What is the 3-year average Enterprise Value for Mesoblast Limited (MESO)?

What is the 5-year average Enterprise Value for Mesoblast Limited (MESO)?

How does the current Enterprise Value for Mesoblast Limited (MESO) compare to its historical average?